The Indian government informed Parliament that India and the US are engaged in negotiations for a mutually beneficial multi-sectoral bilateral trade agreement. The two countries also cooperate on strategic, economic, and defense matters, managing divergences through high-level dialogues.
rediffGURU Chocko Valliappa offers crucial career advice to engineering aspirants.
Prime Minister Narendra Modi met with Indian-American billionaire entrepreneur Vivek Ramaswamy and SpaceX CEO Elon Musk in Washington, D.C., discussing India-US relations, innovation, biotechnology, and the role of entrepreneurship. Modi also met with US National Security Advisor Michael Waltz and Director of National Intelligence Tulsi Gabbard during his visit.
In a double-dose bid to boost growth and employment prospects, the Union Cabinet on Tuesday approved a Rs 2.07 trillion outlay for a research development and innovation (RDI) Scheme to fund private sector innovations, and an employment-linked incentive (ELI) to create over 35 million new jobs over the next two years.
The Indian Diaspora has been able to carve a niche in their adopted countries as a result of their talent, perseverance and hardworking nature, asserts Rup Narayan Das.
A total of 43 districts in India are currently reporting AES cases.
Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.
After reports claimed that filings in patent offices in India, the US, and Europe did not mention ICMR or its scientists, but only BBIL and its scientists, the Hyderabad-based biotechnology (biotech) company clarified that in the "rush" to develop vaccines and file appropriate patents, BBIL had missed adding ICMR's name in the original filings.
The Centre has taken a major step towards increasing efficiency in decision-making by empowering joint secretaries to report to secretaries directly, officials said on Wednesday.
Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.
JNU students staged a march from Mandi House to Jantar Mantar demanding expedited efforts to trace the student. A delegation of JNU students union went to submit a memorandum to the office of Lieutenant Governor Najeeb Jung in this regard.
India and the US on Friday said they have started talks to put in place a strategic framework for human space flight by year-end as they plan to send an Indian astronaut to the International Space Station in 2024.
Addressing a press briefing, Union Health Secretary Rajesh Bhushan said healthcare workers and frontline workers need not register themselves as their database has been populated on to the Co-WIN vaccine delivery management system in a bulk manner.
"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.
The spectator size too has been reduced to 25,000, officials said.
Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.
Several professors of Jawaharlal Nehru University and other institutions have accused a former JNU employee of duping them of crores of rupees promising them homes on a Delhi Development Authority (DDA) plot under a housing development scheme which was never there.
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
As a proactive step, the government has already placed nations, where this VoC has been found, in the category of 'at risk' countries for additional follow-up measures of international travellers coming into lndia from these destinations, he said in a letter dated November 27.
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
Bangalore's information and biotechnology majors have again trained their guns at the government over the closure of the existing HAL airport.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
B S Yediyurappa, deputy chief minister designate of the new Bharatiya Janata Party-Janata Dal (Secular) coalition government to be sworn-in in Karnataka on February 3, Sunday said the government would formulate a Common Minimum Programme.
The move is expected to create space for more budding entrepreneurs in the country to be eligible for self-certification, relaxed public procurement norms, rebate in patent filing, start-up funding, investment and easier closure compliance.
While Karnataka reported five new cases, Delhi and Telangana reported four each, and Gujarat reported one fresh case of the Omicron variant.
"Also, 35 per cent deaths were recorded in the age group of 45-60 years, 10 per cent in the age group of 26-44 years and one per cent each in the age group of 18-25 years and below 17 years," the health secy said.
'Defence funding is channelled to State-owned research organisations where scientists are merely bureaucrats holding meetings and sending out minutes of meetings and press releases, but have long ago stopped any innovative work.' 'Unless this tragedy is fixed, India's chances to create world-conquering and job-creating new industries are slim,' says Ajit Balakrishnan.
The board would take a decision on these applications on February 20.
The decision marks first successful policy intervention.
About 80 per cent of the companies that are registered are essentially non-IT.
Presenting the Top 20 of 100 science colleges as per India Today's findings.
Presenting the Top 20 of 100 science colleges as per India Today's findings.
Seven months down the line, not much progress has been made, except that the scheme is still being fine-tuned.
This is the joint statement issued by the ministry of external affairs on the visit of US President Barack Obama to India.
Modi government is pushing GM food crops without adequate safety assessment and transparency, claim activists.
'It is very important for Indian Americans to understand that we need to have as many seats at the table as we can get. I am going to see to it that I am going to get there," Kumar Barve, the longest-serving Indian-American legislator in America, tells Aziz Haniffa/Rediff.com in an exclusive interview.
With an aggressive Opposition and unyielding government, important legislation could be the biggest casualty, as details of the helicopter contract surface.
'Let me talk about young Indian startups with their hearts in the right place and how they are proving that innovations that represent 'affordable excellence' -- breaking the myth that 'affordability' and 'excellence' cannot go together -- is indeed possible!' says Dr R A Mashelkar, the eminent scientist, in this fascinating feature.